SCHEMBL6529863

SCHEMBL6529863

CCCOc1c(C#N)c(N2CCNCC2)nc2ccc(OC)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 1/20 0.47
▸ KDM4E B2RXH2 6/20 0.45
▸ ALDH1A1 P00352 6/20 0.45
▸ HPGD P15428 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TAAR1 Q96RJ0 1/20 0.45
▸ KMT2A Q03164 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ CASP1 P29466 4/20 0.43
▸ CASP7 P55210 4/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RUNX1 Q01196 1/20 0.43
▸ CBFB Q13951 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ TP53 P04637 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20975373 0.85 KDM4E (0.46) NCF1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL6529865 0.82 PDE10A (0.50) NCF1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21335097 0.81 KDM4E (0.40) KDM4EALDH1A1KMT2AMEN1CASP1
SCHEMBL16416202 0.70 HTR6 (0.63) NCF1PDE10ATP53CYP1A2CYP3A4
SCHEMBL12495116 0.70 HTR2C (0.39) KDM4EALDH1A1HPGDSMN1; SMN2TAAR1
SCHEMBL1222766 0.69 CYP1A2 (0.76) NCF1KDM4EALDH1A1HPGDKMT2A
SCHEMBL20975374 0.68 PDE10A (0.44) NCF1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5133305 0.67 MEN1 (0.51) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL3678007 0.67 NCF1 (0.61) NCF1TP53CYP1A2CYP3A4USP2
SCHEMBL4744379 0.66 ALDH1A1 (0.50) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005047259-A1 4-ANILINO-3-QUINOLINECARBONITRILES FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WYETH (US) 2005-05-26 — — WO disclosed
Send feedback